Abstract Details
Activity Number:
|
582
|
Type:
|
Topic Contributed
|
Date/Time:
|
Wednesday, August 7, 2013 : 2:00 PM to 3:50 PM
|
Sponsor:
|
Biopharmaceutical Section
|
Abstract - #307648 |
Title:
|
Ensuring Assay Sensitivity in Analysis of Noninferiority Trials with Missing Data
|
Author(s):
|
Brian Wiens*+
|
Companies:
|
Alcon Laboratories
|
Keywords:
|
per protocol ;
intent to treat ;
longitudinal data ;
clinical trials
|
Abstract:
|
We consider methods for ensuring assay sensitivity in active control, non-inferiority trials. Bias in assessment of comparative treatment effects can result in an increased or decreased chance of rejecting the null hypothesis compared to the nominal rate. A non-inferiority trial with biased estimation of treatment effects may have an increased rate of concluding no difference, even when the investigational treatment is importantly worse than the active control. Thus, controlling bias and ensuring assay sensitivity are similar goals. One popular, ad hoc method of ensuring assay sensitivity is use a per protocol analysis set. We consider advantages and disadvantages of the per protocol analysis set and conclude that the disadvantages are numerous and all advantages can be found in other, principled methods of controlling bias and assay sensitivity.
|
Authors who are presenting talks have a * after their name.
Back to the full JSM 2013 program
|
2013 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.